Research letters - page 4

Denser fibrin clot networks in patients at high risk of recurrent arterial thromboembolism following acute limb ischemia of unknown cause

Tomasz Nowakowski, Krzysztof Batko, Anetta Undas

Pol Arch Intern Med. 2022, Vol. 132, No. 11: 16358 / DOI: 10.20452/pamw.16358

Relationship between COVID-19 severity, markers of endothelial impairment, and Simple Covid Risk Index

Mateusz Fabiś, Paulina Gorzelak-Pabiś, Joanna Satała, Agnieszka Pawlos, Jarosław Fabiś, Marlena Broncel

Pol Arch Intern Med. 2022, Vol. 132, No. 10: 16348 / DOI: 10.20452/pamw.16348

Safety and feasibility of single-day coronary angioplasty in low- and moderate-risk patients: candidate selection criteria, management protocol, and outcomes

Andrzej Ciszewski

Pol Arch Intern Med. 2022, Vol. 132, No. 10: 16330 / DOI: 10.20452/pamw.16330

Unfavorably altered fibrin clot properties are associated with recurrent venous thromboembolism in patients following post‑discharge events

Kamila W. Undas, Jakub Siudut, Michał Ząbczyk

Pol Arch Intern Med. 2022, Vol. 132, No. 9: 16326 / DOI: 10.20452/pamw.16326

Revascularization in patients with ST‑segment elevation myocardial infarction and multivessel coronary artery disease: preliminary results from a large multicenter national registry

Marcin Sadowski, Krzysztof Milewski, Łukasz Zandecki, Michał Skrzypek, Mariusz Gąsior, Wojciech Wojakowski

Pol Arch Intern Med. 2022, Vol. 132, No. 9: 16315 / DOI: 10.20452/pamw.16315

A series of Polish patients with congenital fibrinogen disorders: 2 new mutations in fibrinogen gamma chain, Fibrinogen Kostrzyn and Fibrinogen Łódź II

Anna Weronska, Anna Klukowska, Marguerite Neerman-Arbez, Jacek Treliński, Anetta Undas, Ewa Wypasek

Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16314 / DOI: 10.20452/pamw.16314

Treatment of acute coronary syndromes during the COVID‑19 pandemic: a designated COVID‑19 hospital perspective

Marek Słomczyński, Janusz Rzeźniczak, Dominika Kasprzak, Paweł Bugajski, Andrzej Bolewski, Paweł Burchardt

Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16298 / DOI: 10.20452/pamw.16298

Increased endocan expression as a biomarker of endothelial dysfunction in patients with metabolic syndrome

Sylwia Iwańczyk, Anna Smukowska-Gorynia, Patrycja Woźniak, Marek Grygier, Maciej Lesiak, Aleksander Araszkiewicz

Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16292 / DOI: 10.20452/pamw.16292

Changes of lipid profile in subclinical hyperthyroidism and following restoration of euthyroidism

Grzegorz Kamiński, Michał Olejarz, Ewelina Szczepanek-Parulska, Marek Ruchała, Marek Saracyn

Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16277 / DOI: 10.20452/pamw.16277

Altered fecal short‑chain fatty acid profile as a potential marker of disease activity in patients with ulcerative colitis and Crohn’s disease: a pilot study

Olga Kaczmarczyk, Agnieszka Dąbek-Drobny, Michał Woźniakiewicz, Paweł Paśko, Agnieszka Piątek-Guziewicz, Małgorzata Zwolińska-Wcisło

Pol Arch Intern Med. 2022, Vol. 132, No. 6: 16254 / DOI: 10.20452/pamw.16254

Association between interleukin 17A levels and left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation

Liangjie Xu, Tinpan Fan, Yi Liang, Cuicui Zhou, Xinxin Chen, Wei Yuan

Pol Arch Intern Med. 2022, Vol. 132, No. 6: 16252 / DOI: 10.20452/pamw.16252

A comprehensive study of persistent changes on lung computed tomography scans of convalescent patients 3 months after recovery from severe and moderate COVID‑19 pneumonia

Ewa Kurys-Denis, Anna Grzywa-Celińska, Miłosz Kawa

Pol Arch Intern Med. 2022, Vol. 132, No. 5: 16242 / DOI: 10.20452/pamw.16242

Serum matrix metalloproteinase‑8 level in patients with coronary artery abnormal dilatation

Sylwia Iwańczyk, Tomasz Lehmann, Marek Grygier, Patrycja Woźniak, Maciej Lesiak, Aleksander Araszkiewicz

Pol Arch Intern Med. 2022, Vol. 132, No. 5: 16241 / DOI: 10.20452/pamw.16241

Prognostic significance associated with the number of compound mutations in epidermal growth factor receptor–mutated non–small cell lung cancer

Hiroaki Satoh, Yuika Sasatani, Kunihiko Miyazaki, Yoshiharu Sato, Nobuyuki Hizawa

Pol Arch Intern Med. 2022, Vol. 132, No. 4: 16240 / DOI: 10.20452/pamw.16240

Dyslipidemia as an important risk factor for gastric adenomatous polyps in patients with gastric polyps

Lei Feng, Zhen Li, Yufeng Gu, Yanling Mu, Yong Yao, Meiling Shu

Pol Arch Intern Med. 2022, Vol. 132, No. 4: 16238 / DOI: 10.20452/pamw.16238

Effectiveness of a modified doxorubicin-etoposide-methylprednisolone regimen for the treatment of refractory or relapsed macrophage activation syndrome in adults

Lingbo He, Zhili Jin, Menghan Liu, Ruoxi Zhang, Zhao Wang, Yini Wang

Pol Arch Intern Med. 2022, Vol. 132, No. 3: 16226 / DOI: 10.20452/pamw.16226

Allogeneic hematopoietic stem cell transplantation for relapsed B‑cell acute lymphoblastic leukemia after failure of autologous hematopoietic stem cell transplantation: a retrospective single-center analysis

Marta Panz-Klapuch, Adrianna Spałek, Katarzyna Duda, Anna Kopińska, Agata Wieczorkiewicz-Kabut, Grzegorz Helbig

Pol Arch Intern Med. 2022, Vol. 132, No. 3: 16220 / DOI: 10.20452/pamw.16220

Methylenetetrahydrofolate reductase (MTHFR) gene c.665C>T and c.1286A>C and SERPINE1 –675 4G/5G polymorphisms in Polish patients with venous thromboembolism and cryptogenic ischemic stroke

Adrianna Klajmon, Mariusz Cichoń, Joanna Natorska, Anetta Undas, Ewa Wypasek

Pol Arch Intern Med. 2022, Vol. 132, No. 2: 16218 / DOI: 10.20452/pamw.16218

Stratification of cardiovascular disease risk in adults receiving long‑term home parenteral nutrition

Marta Leńska-Mieciek, Paulina Jurczak-Kobus, Aleksandra Kuls-Oszmaniec, Urszula Fiszer, Jacek Sobocki

Pol Arch Intern Med. 2022, Vol. 132, No. 2: 16207 / DOI: 10.20452/pamw.16207

Long‑term mortality and risk factor analysis in hypertrophic cardiomyopathy patients with implantable cardioverter‑defibrillators

Szymon Mielczarek, Paweł Syska, Michał Lewandowski, Ilona Kowalik, Mariusz Pytkowski, Hanna Szwed

Pol Arch Intern Med. 2022, Vol. 132, No. 2: 16206 / DOI: 10.20452/pamw.16206

previousof 13next

Impact Factor 2023

3.8

Quartile in the category

IC value for 2022

217.18

Ministry of Education and Science score

200

Average times from:
submission to 1st decision, 2 days
submission to first reviews, 24 days
acceptance to online first publication, 5 days
acceptance to final publication, 45 days

Current manuscript acceptance rate: 27%

The journal is co-financed from the state budget under the "Development of scientific journals" program of the Ministry of Education and Science in the years 2022-2024. Read more